The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy

NCT06597539 · clinicaltrials.gov ↗
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ruijin Hospital